Development of respiratory control instability in heart failure: a novel approach to dissect the pathophysiological mechanisms.
Observational data suggest that periodic breathing is more common in subjects with low F(ETCO(2)), high apnoeic thresholds or high chemoreflex sensitivity. It is, however, difficult to determine the individual effect of each variable because they are intrinsically related. To distinguish the effect of isolated changes in chemoreflex sensitivity, mean F(ETCO(2)) and apnoeic threshold, we employed a modelling approach to break their obligatory in vivo interrelationship. We found that a change in mean CO(2) fraction from 0.035 to 0.045 increased loop gain by 70 +/- 0.083% (P < 0.0001), irrespective of chemoreflex gain or apnoea threshold. A 100% increase in the chemoreflex gain (from 800 l min(-1) (fraction CO(2))(-1)) resulted in an increase in loop gain of 275 +/- 6% (P < 0.0001) across a wide range of values of steady state CO(2) and apnoea thresholds. Increasing the apnoea threshold F(ETCO(2)) from 0.02 to 0.03 had no effect on system stability. Therefore, of the three variables the only two destabilizing factors were high gain and high mean CO(2); the apnoea threshold did not independently influence system stability. Although our results support the idea that high chemoreflex gain destabilizes ventilatory control, there are two additional potentially controversial findings. First, it is high (rather than low) mean CO(2) that favours instability. Second, high apnoea threshold itself does not create instability. Clinically the apnoea threshold appears important only because of its associations with the true determinants of stability: chemoreflex gain and mean CO(2).
Manisty
Charlotte H
CH
International Centre for Circulatory Health, St Mary's Hospital and Imperial College of Science and Medicine, London, UK. cmanisty@ic.ac.uk
Willson
Keith
K
Wensel
Roland
R
Whinnett
Zachary I
ZI
Davies
Justin E
JE
Oldfield
William L G
WL
Mayet
Jamil
J
Francis
Darrel P
DP
D000818:Animals; D001049:Apnea / Q000503:physiopathology*; D002245:Carbon Dioxide / Q000378:metabolism*; D002628:Chemoreceptor Cells; D003198:Computer Simulation; D005246:Feedback; D006333:Heart Failure / Q000150:complications / Q000503:physiopathology*; D006801:Humans; D008954:Models, Biological; D012123:Pulmonary Ventilation; D012018:Reflex; D015656:Respiratory Mechanics
D002245:Carbon Dioxide